ALN-AT3SC-009


Study NameStudy TitleStudy TypeSponsorSponsor Type
ALN-AT3SC-009A Phase 3 study to describe the efficacy and safety of Fitusiran prophylaxis in hemophilia A and B patients previously receiving factor or bypassing agent prophylaxis.Clinical Trial of IMPSanofi GenzymeIndustry supported